The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKibo Energy Regulatory News (KIBO)

Share Price Information for Kibo Energy (KIBO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0375
Bid: 0.035
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.005 (14.286%)
Open: 0.0375
High: 0.0375
Low: 0.0375
Prev. Close: 0.0375
KIBO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kibo Subsidiary - Update on the Completion of JVA

23 Oct 2023 07:00

RNS Number : 8853Q
Kibo Energy PLC
23 October 2023
 

Kibo Energy PLC (Incorporated in Ireland)

(Registration Number: 451931)

(External registration number: 2011/007371/10)

LEI Code: 635400WTCRIZB6TVGZ23

Share code on the JSE Limited: KBO

Share code on the AIM: KIBO

ISIN: IE00B97C0C31

('Kibo' or 'the Company')

 

Dated: 23 October 2023

Kibo Energy PLC ('Kibo' or the 'Company')

 

Kibo Subsidiary Announces Update on the Completion of Its Binding Joint Venture Agreement

 

Kibo Energy PLC (AIM: KIBO; AltX: KBO), the renewable energy-focused development company, announces that further to its previous announcements dated 12 July 2023, 4 August 2023, 1 September 2023 and 22 September 2023, respectively, its subsidiary Mast Energy Developments PLC ('MED'), a UK-based multi-asset owner, developer and operator in the rapidly growing flexible market, has today signed a replacement first definitive and binding Joint Venture Agreement ('JVA') with Proventure Holdings (UK) Ltd, part of the Proventure Group ('Proventure'). This follows a rearrangement of the investor consortium participation as previously set out in a Company RNS dated 1 September 2023.

 

The terms of the replacement JVA are the same in all material aspects as that of the previous JVA, as noted in a Company announcement dated 12 July 2023. Further, under the terms of the JVA, Proventure is required to make an initial interim payment of £2,000,000 (the 'Interim Payment') to the Joint Venture Special Purpose Vehicle ('SPV'), to be received no later than 10 November 2023. The consortium's proof of funds has already been provided by Proventure. As such, MED has extended the completion long-stop date for the JVA as well as the payment of the balance of the investment, amounting to c. £3.9 million, by no later than 30 November 2023. The JVA further commits both parties to promptly finalise terms on a second joint venture as previously detailed in an announcement dated 12 July 2023.

 

Louis Coetzee, CEO of Kibo Energy, says: "We are pleased that MED is partnering with a reputable institutional investor such as Proventure and have full confidence that the parties will conclude the transaction in accordance with the revised long-stop date, paving the way for the further success of the second joint venture."

 

Further details can be found in the full MED announcement, which is available below and at med.energy:

 

-------------------------

Dated: 23 October 2023

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

MED Binding Joint Venture Agreement Completion Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcements dated 12 July 2023, 4 August 2023, 1 September 2023, and 22 September 2023 respectively, it has today signed a replacement first definitive and binding Joint Venture Agreement ('JVA') with Proventure Holdings (UK) Ltd which is part of the Proventure Group ('Proventure'), following a rearrangement of the investor consortium participation as set out in our announcement of 1 September 2023. Proventure was founded by Mr. Kona and is an Indian based multi-national group specialising in renewable energy investments globally. The terms of the replacement JVA are the same in all material aspects as that of the previous JVA as set out in our announcement of 12 July 2023. Further, under the terms of the JVA, Proventure is required to make an initial interim payment of £2,000,000 (the "Interim Payment") to the Joint Venture SPV (the "JV"). The Interim Payment must be received by latest 10 November 2023, and the consortium's proof of funds has already been provided by Proventure. As a result, MED has further extended the completion long-stop date for the JVA. The revised completion date and the payment of the balance of the investment due of c. £3.9m is now expected by no later than 30 November 2023 (except where a later date has been agreed by the Company and Proventure, on that date). The further extension is required to allow Proventure to complete the compulsory statutory process, as previously explained. Upon completion of this process, the remaining balance of the JVA funds due will be promptly transferred into the UK to complete the JVA investment.

 

The JVA referred to above also commits both parties, as set out in MED's announcement dated 12 July 2023, to promptly finalise terms on a second joint venture. As such, notwithstanding the extension of completion of the first JVA as referred to above, the parties will endeavour to finalise terms for the second JV promptly.

 

Pieter Krügel, CEO of MED, commented: "We are delighted to have concluded the agreement with the replacement lead-investor, and excited to partner with a well-established and reputable institutional investor such as Proventure. The parties are fully committed to finalise the statutory arrangements required to ensure the successful completion and transfer of funds as quickly as possible. We are confident that we will be able to complete the transaction in accordance with the revised long-stop date."

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

Pieter Krügel

Info@med.energy

Mast Energy Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor & Media Relations Advisor

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulations (EU) no. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this information is now considered to be in the public domain.

**ENDS**

 

For further information please visit www.kibo.energy or contact:

 

Louis Coetzee

info@kibo.energy

Kibo Energy PLC

Chief Executive Officer

James Biddle Roland Cornish

+44 207 628 3396

Beaumont Cornish Limited

Nominated Adviser

Claire Noyce

+44 20 3764 2341

Hybridan LLP

Joint Broker

Damon Heath

+44 207 186 9952

Shard Capital Partners LLP

Joint Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor and Media Relations Consultant

 

Johannesburg

23 October 2023

Corporate and Designated Adviser

River Group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFVIIFLFFIV
Date   Source Headline
7th Jul 20227:00 amRNSFramework Agreement - Long Duration ESS
4th Jul 20227:00 amRNSConvertible Instrument Redemption Date Extension
27th Jun 20224:50 pmRNSAudited AFS for the year ended 31 December 2021
13th Jun 20229:25 amRNSKibo Energy PLC corporate presentation
6th Jun 20229:25 amRNSTR-1 notification of major holdings
30th May 20222:00 pmRNSUpdate on Admission of Shares to AIM & JSE AltX
30th May 20227:00 amRNSLong Duration Energy Storage Projects in SA
27th May 20227:30 amRNSRestoration - Kibo Energy Plc
27th May 20227:00 amRNSUpdate on Acquisition of Brownhill and RTO
20th May 20223:00 pmRNSSettlement of Outstanding Loan and Issue of Shares
20th May 20227:00 amRNSAppointment of Group Chief Financial Officer
17th May 20227:00 amRNSAgreement to deploy 1 GWh Long Duration Storage
3rd May 20227:00 amRNSAmendment to Share Purchase Agreement
1st Apr 20223:00 pmRNSAmendment to Share Purchase Agreement
1st Apr 20227:00 amRNSConvertible Instrument Redemption Date Extension
21st Mar 20227:30 amRNSSuspension - Kibo Energy PLC
21st Mar 20227:00 amRNSAcquisition of Brownhill and Suspension of Trading
1st Mar 202212:00 pmRNSConvertible Instrument Redemtion Date Extension
23rd Feb 20222:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:00 pmRNSPrice Monitoring Extension
16th Feb 20223:15 pmRNSFunding Facility and Issue of Shares
14th Feb 20229:06 amRNSSecond Price Monitoring Extn
14th Feb 20229:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSTen Year PPA on SA Waste to Energy Project Signed
12th Jan 20227:00 amRNSAppointment of Shard Capital Partners LLP
7th Jan 20227:00 amRNSSettlement of Outstanding Fees to Directors
14th Dec 20217:00 amRNSPending Board Change
15th Nov 20217:45 amRNSPyebridge Steady State Operation and Production
10th Nov 20217:00 amRNSIssue of Shares in lieu of Payment to Contractors
8th Nov 20217:45 amRNSReplacement
8th Nov 20217:00 amRNSKatoro Raises £815,000 in Placing
3rd Nov 20217:00 amRNS£860,000 share subscription with Private Investors
20th Oct 20217:05 amRNSMED Signs Term Sheet to Fund Power Projects
19th Oct 20217:00 amRNSESS Inc.
30th Sep 202111:50 amRNSResult of AGM
24th Sep 20218:00 amRNSHalf-year Report
23rd Sep 20217:00 amRNSFunding Update: UK Waste to Energy Project
16th Sep 20218:45 amRNSStrategic Investment in UK Waste to Energy Project
16th Aug 20217:25 amRNSMED acquires Third Standby Generation Facility
12th Aug 20217:20 amRNSMED acquires 9 MW Pyebridge Gas-powered Facility
30th Jul 20217:00 amRNSCompletion of Agreement with IGES
15th Jul 20212:00 pmRNSPrice Monitoring Extension
15th Jul 202111:05 amRNSSecond Price Monitoring Extn
15th Jul 202111:00 amRNSPrice Monitoring Extension
15th Jul 20219:05 amRNSSecond Price Monitoring Extn
15th Jul 20219:00 amRNSPrice Monitoring Extension
24th Jun 20218:00 amRNSHolding(s) in Company TR 1
24th Jun 20217:50 amRNSHolding(s) in Company TR 1
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.